학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 13건 | 목록
1~20
Aging affects reprogramming of pulmonary capillary endothelial cells after lung injury in male mice.
Academic Journal
Truchi M; Université Côte d'Azur, UMR CNRS 7275 Inserm U1323, IPMC, Valbonne, France.; IHU RespirERA, Université Côte d'Azur, Nice, France.; Gautier-Isola M; Université Côte d'Azur, UMR CNRS 7275 Inserm U1323, IPMC, Valbonne, France.; IHU RespirERA, Université Côte d'Azur, Nice, France.; Savary G; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020 CNRS - U1277 Inserm - CANTHER, Lille, France.; Scribe C; Université Côte d'Azur, UMR CNRS 7275 Inserm U1323, IPMC, Valbonne, France.; IHU RespirERA, Université Côte d'Azur, Nice, France.; Lingampally A; Cardio-Pulmonary Institute (CPI) and Department of Pulmonary and Critical Care Medicine and Infectious Diseases, Universities of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus-Liebig-University (JLU), Giessen, Germany.; Institute for Lung Health (ILH), Giessen, Germany.; Cadis H; Université Côte d'Azur, UMR CNRS 7275 Inserm U1323, IPMC, Valbonne, France.; IHU RespirERA, Université Côte d'Azur, Nice, France.; Baeri A; Université Côte d'Azur, UMR CNRS 7275 Inserm U1323, IPMC, Valbonne, France.; Magnone V; Université Côte d'Azur, UMR CNRS 7275 Inserm U1323, IPMC, Valbonne, France.; IHU RespirERA, Université Côte d'Azur, Nice, France.; Girard-Riboulleau C; Université Côte d'Azur, UMR CNRS 7275 Inserm U1323, IPMC, Valbonne, France.; Arguel MJ; Université Côte d'Azur, UMR CNRS 7275 Inserm U1323, IPMC, Valbonne, France.; IHU RespirERA, Université Côte d'Azur, Nice, France.; de Schutter C; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020 CNRS - U1277 Inserm - CANTHER, Lille, France.; Fassy J; Université Côte d'Azur, UMR CNRS 7275 Inserm U1323, IPMC, Valbonne, France.; IHU RespirERA, Université Côte d'Azur, Nice, France.; Boukrout N; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020 CNRS - U1277 Inserm - CANTHER, Lille, France.; Larrue R; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020 CNRS - U1277 Inserm - CANTHER, Lille, France.; Martin N; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020 CNRS - U1277 Inserm - CANTHER, Lille, France.; Rezzonico R; Université Côte d'Azur, UMR CNRS 7275 Inserm U1323, IPMC, Valbonne, France.; IHU RespirERA, Université Côte d'Azur, Nice, France.; Pluquet O; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020 CNRS - U1277 Inserm - CANTHER, Lille, France.; Perrais M; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020 CNRS - U1277 Inserm - CANTHER, Lille, France.; Hofman V; IHU RespirERA, Université Côte d'Azur, Nice, France.; Laboratory of Clinical and Experimental Pathology and Biobank Côte d'Azur BB-0033-00025, Centre Hospitalier Universitaire de Nice, Nice, France.; Université Côte d'Azur, UMR 7413 CNRS Inserm U1081, IRCAN, Nice, France.; Marquette CH; IHU RespirERA, Université Côte d'Azur, Nice, France.; Université Côte d'Azur, UMR 7413 CNRS Inserm U1081, IRCAN, Nice, France.; Department of Pulmonary Medicine and Thoracic Oncology, Centre Hospitalier Universitaire de Nice, Nice, France.; Hofman P; IHU RespirERA, Université Côte d'Azur, Nice, France.; Laboratory of Clinical and Experimental Pathology and Biobank Côte d'Azur BB-0033-00025, Centre Hospitalier Universitaire de Nice, Nice, France.; Université Côte d'Azur, UMR 7413 CNRS Inserm U1081, IRCAN, Nice, France.; Günther A; Cardio-Pulmonary Institute (CPI) and Department of Pulmonary and Critical Care Medicine and Infectious Diseases, Universities of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus-Liebig-University (JLU), Giessen, Germany.; Institute for Lung Health (ILH), Giessen, Germany.; European IPF Registry and Biobank, Giessen, Germany.; Lung Clinic, Agaplesion Evangelisches Krankenhaus Mittelhessen, Giessen, Germany.; Ricard N; BioSanté unit U1292, Grenoble Alpes University, INSERM, CEA, Grenoble, France.; Barbry P; Université Côte d'Azur, UMR CNRS 7275 Inserm U1323, IPMC, Valbonne, France.; IHU RespirERA, Université Côte d'Azur, Nice, France.; 3IA Côte d'Azur, Université Côte d'Azur, Sophia Antipolis, France.; Leroy S; Université Côte d'Azur, UMR CNRS 7275 Inserm U1323, IPMC, Valbonne, France.; IHU RespirERA, Université Côte d'Azur, Nice, France.; Department of Pulmonary Medicine and Thoracic Oncology, Centre Hospitalier Universitaire de Nice, Nice, France.; Lebrigand K; Université Côte d'Azur, UMR CNRS 7275 Inserm U1323, IPMC, Valbonne, France.; IHU RespirERA, Université Côte d'Azur, Nice, France.; Bellusci S; Cardio-Pulmonary Institute (CPI) and Department of Pulmonary and Critical Care Medicine and Infectious Diseases, Universities of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus-Liebig-University (JLU), Giessen, Germany.; Institute for Lung Health (ILH), Giessen, Germany.; Cauffiez C; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020 CNRS - U1277 Inserm - CANTHER, Lille, France.; Vassaux G; Université Côte d'Azur, UMR CNRS 7275 Inserm U1323, IPMC, Valbonne, France.; IHU RespirERA, Université Côte d'Azur, Nice, France.; Pottier N; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020 CNRS - U1277 Inserm - CANTHER, Lille, France.; Mari B; Université Côte d'Azur, UMR CNRS 7275 Inserm U1323, IPMC, Valbonne, France. mari@unice.fr.; IHU RespirERA, Université Côte d'Azur, Nice, France. mari@unice.fr.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Larrue R; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France. romain.larrue@chu-lille.fr.; Service de Toxicologie et Génopathies, CHU Lille, F-59000, Lille, France. romain.larrue@chu-lille.fr.; Fellah S; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Hennart B; Service de Toxicologie et Génopathies, CHU Lille, F-59000, Lille, France.; Sabaouni N; Service de Toxicologie et Génopathies, CHU Lille, F-59000, Lille, France.; Boukrout N; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Van der Hauwaert C; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Delage C; Service de Toxicologie et Génopathies, CHU Lille, F-59000, Lille, France.; Cheok M; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Perrais M; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Cauffiez C; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Allorge D; Service de Toxicologie et Génopathies, CHU Lille, F-59000, Lille, France.; Pottier N; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Service de Toxicologie et Génopathies, CHU Lille, F-59000, Lille, France.
Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101083949 Publication Model: Electronic Cited Medium: Internet ISSN: 1473-1150 (Electronic) Linking ISSN: 1470269X NLM ISO Abbreviation: Pharmacogenomics J Subsets: MEDLINE; PubMed not MEDLINE
Academic Journal
Hamroun A; Nephrology, Public Health-Epidemiology, Lille University Hospital Center, Lille, France.; UMR1167 RID-AGE, Institut Pasteur de Lille, Inserm, Lille University, Lille University Hospital Center, Lille, France.; Boukrout N; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.; Cauffiez C; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.; Fellah S; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.; Van der Hauwaert C; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.; Pottier N; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.; Mentaverri R; Amiens University Hospital, Human Biology Center, Amiens, France.; UR 7517 UPJV, Pathophysiological Mechanisms and Consequences of Cardiovascular Calcifications (MP3CV), Picardie Jules Verne University, Amiens, France.; Zaworski J; Inserm, UMR S 1155, Physiology Unit, Hôpital Tenon, Sorbonne Université, Paris, France.; Gnemmi V; Service d'Anatomie Pathologique, Centre de Biologie Pathologique, CHU Lille, Lille, France.; Gibier JB; Service d'Anatomie Pathologique, Centre de Biologie Pathologique, CHU Lille, Lille, France.; Letavernier E; Inserm, UMR S 1155, Physiology Unit, Hôpital Tenon, Sorbonne Université, Paris, France.; Louvet A; Liver Unit, Lille University Hospital Center, Lille, France.; Provôt F; Nephrology, Lille University Hospital Center, Lille, France.; Lenain R; Nephrology, Lille University Hospital Center, Lille, France.; Maanaoui M; Nephrology, Lille University Hospital Center, Lille, France.; Glowacki F; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.; Nephrology, Lille University Hospital Center, Lille, France.; Lionet A; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.; Nephrology, Lille University Hospital Center, Lille, France.
Publisher: Oxford University Press Country of Publication: England NLM ID: 101579321 Publication Model: eCollection Cited Medium: Print ISSN: 2048-8505 (Print) Linking ISSN: 20488505 NLM ISO Abbreviation: Clin Kidney J Subsets: PubMed not MEDLINE
Academic Journal
Pancreatology. 20:S142-S143
Academic Journal
Larrue R; University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, 59000, Lille, France.; Fellah S; University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, 59000, Lille, France.; Boukrout N; University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, 59000, Lille, France.; De Sousa C; University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, 59000, Lille, France.; Lemaire J; University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, 59000, Lille, France.; Leboeuf C; University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, 59000, Lille, France.; Goujon M; University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, 59000, Lille, France.; Perrais M; University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, 59000, Lille, France.; Mari B; Université Côte d'Azur, CNRS UMR7275, IPMC, FHU-OncoAge, IHU RespiERA, 06560, Valbonne, France.; Cauffiez C; University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, 59000, Lille, France.; Pottier N; University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, 59000, Lille, France.; Van der Hauwaert C; University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, 59000, Lille, France. cynthia.vanderhauwaert@inserm.fr.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE
Academic Journal
Delage C; Service de Toxicologie et Génopathies, CHU Lille, F-59000, Lille, France.; Andreani M; Service de Néphrologie, CHU de Nice, F-06000, Nice, France.; Boukrout N; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Sabaouni N; Service de Toxicologie et Génopathies, CHU Lille, F-59000, Lille, France.; Perrais M; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Lefebvre B; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Cauffiez C; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Pottier N; Service de Toxicologie et Génopathies, CHU Lille, F-59000, Lille, France.; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Larrue R; Service de Toxicologie et Génopathies, CHU Lille, F-59000, Lille, France.; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.
Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101672560 Publication Model: eCollection Cited Medium: Print ISSN: 2405-8440 (Print) Linking ISSN: 24058440 NLM ISO Abbreviation: Heliyon Subsets: PubMed not MEDLINE
Academic Journal
Bourdon E; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Swierczewski T; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Goujon M; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Boukrout N; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Fellah S; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Van der Hauwaert C; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Larrue R; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; CHU Lille, Service de Toxicologie et Génopathies, F-59000 Lille, France.; Lefebvre B; Univ. Lille, CNRS, Inserm, CHU Lille, UMR-S1172, Neuroscience & Cognition, Alzheimer & Tauopathies, F-59000 Lille, France.; Van Seuningen I; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Cauffiez C; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Pottier N; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Univ. Lille, CNRS, Inserm, CHU Lille, UMR-S1172, Neuroscience & Cognition, Alzheimer & Tauopathies, F-59000 Lille, France.; Perrais M; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Academic Journal
Larrue R; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France. romain.larrue@chu-lille.fr.; Service de Toxicologie et Génopathies, CHU Lille, F-59000, Lille, France. romain.larrue@chu-lille.fr.; Fellah S; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Hennart B; Service de Toxicologie et Génopathies, CHU Lille, F-59000, Lille, France.; Sabaouni N; Service de Toxicologie et Génopathies, CHU Lille, F-59000, Lille, France.; Boukrout N; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Van der Hauwaert C; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Delage C; Service de Toxicologie et Génopathies, CHU Lille, F-59000, Lille, France.; Cheok M; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Perrais M; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Cauffiez C; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Allorge D; Service de Toxicologie et Génopathies, CHU Lille, F-59000, Lille, France.; Pottier N; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Service de Toxicologie et Génopathies, CHU Lille, F-59000, Lille, France.
Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101083949 Publication Model: Electronic Cited Medium: Internet ISSN: 1473-1150 (Electronic) Linking ISSN: 1470269X NLM ISO Abbreviation: Pharmacogenomics J Subsets: MEDLINE
Academic Journal
Dewaeles E; University of Lille, INSERM, CNRS, CHU Lille, UMR9020-U1277, CANTHER, Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.; University of Lille, INSERM, CHU Lille, UMR-S1172 LilNCog, Lille Neuroscience and Cognition, Lille, France.; Carvalho K; University of Lille, INSERM, CHU Lille, UMR-S1172 LilNCog, Lille Neuroscience and Cognition, Lille, France.; Alzheimer and Tauopathies, LabEx DISTALZ, Lille, France.; Fellah S; University of Lille, INSERM, CNRS, CHU Lille, UMR9020-U1277, CANTHER, Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.; Sim J; Department of Physiology, Michigan State University, East Lansing, Michigan, USA.; Cell and Molecular Biology Graduate program, Michigan State University, East Lansing, Michigan, USA.; Boukrout N; University of Lille, INSERM, CNRS, CHU Lille, UMR9020-U1277, CANTHER, Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.; Caillierez R; University of Lille, INSERM, CHU Lille, UMR-S1172 LilNCog, Lille Neuroscience and Cognition, Lille, France.; Alzheimer and Tauopathies, LabEx DISTALZ, Lille, France.; Ramakrishnan H; Department of Physiology, Michigan State University, East Lansing, Michigan, USA.; Van der Hauwaert C; University of Lille, INSERM, CNRS, CHU Lille, UMR9020-U1277, CANTHER, Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.; CHU Lille, Département de la Recherche en Santé, Lille, France.; Vijaya Shankara J; University of Lille, INSERM, CHU Lille, UMR-S1172 LilNCog, Lille Neuroscience and Cognition, Lille, France.; Alzheimer and Tauopathies, LabEx DISTALZ, Lille, France.; Martin N; University of Lille, INSERM, CNRS, CHU Lille, UMR9020-U1277, CANTHER, Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.; Massri N; Department of Physiology, Michigan State University, East Lansing, Michigan, USA.; Cell and Molecular Biology Graduate program, Michigan State University, East Lansing, Michigan, USA.; Launay A; University of Lille, INSERM, CHU Lille, UMR-S1172 LilNCog, Lille Neuroscience and Cognition, Lille, France.; Alzheimer and Tauopathies, LabEx DISTALZ, Lille, France.; Folger JK; Department of Physiology, Michigan State University, East Lansing, Michigan, USA.; de Schutter C; University of Lille, INSERM, CNRS, CHU Lille, UMR9020-U1277, CANTHER, Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.; Larrue R; University of Lille, INSERM, CNRS, CHU Lille, UMR9020-U1277, CANTHER, Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.; CHU Lille, Service de Toxicologie et Génopathies, Lille, France.; Loison I; University of Lille, INSERM, CNRS, CHU Lille, UMR9020-U1277, CANTHER, Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.; Goujon M; University of Lille, INSERM, CNRS, CHU Lille, UMR9020-U1277, CANTHER, Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.; Jung M; University of Strasbourg, CNRS UMR 7104, INSERM U1258 - GenomEast Platform - IGBMC - Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France.; Le Gras S; University of Strasbourg, CNRS UMR 7104, INSERM U1258 - GenomEast Platform - IGBMC - Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France.; Gomez-Murcia V; University of Lille, INSERM, CHU Lille, UMR-S1172 LilNCog, Lille Neuroscience and Cognition, Lille, France.; Alzheimer and Tauopathies, LabEx DISTALZ, Lille, France.; Faivre E; University of Lille, INSERM, CHU Lille, UMR-S1172 LilNCog, Lille Neuroscience and Cognition, Lille, France.; Alzheimer and Tauopathies, LabEx DISTALZ, Lille, France.; Lemaire J; University of Lille, INSERM, CNRS, CHU Lille, UMR9020-U1277, CANTHER, Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.; Garat A; CHU Lille, Service de Toxicologie et Génopathies, Lille, France.; University of Lille, CHU Lille, Institut Pasteur de Lille, ULR 4483, IMPact de l'Environnement Chimique sur la Santé Humaine (IMPECS), Lille, France.; Beauval N; CHU Lille, Service de Toxicologie et Génopathies, Lille, France.; University of Lille, CHU Lille, Institut Pasteur de Lille, ULR 4483, IMPact de l'Environnement Chimique sur la Santé Humaine (IMPECS), Lille, France.; Maboudou P; CHU Lille, Service de Biochimie Automatisée, Protéines et Biologie Prédictive, Lille, France.; Gnemmi V; University of Lille, INSERM, CNRS, CHU Lille, UMR9020-U1277, CANTHER, Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.; CHU Lille, Service d'Anatomopathologie, Lille, France.; Gibier JB; University of Lille, INSERM, CNRS, CHU Lille, UMR9020-U1277, CANTHER, Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.; CHU Lille, Service d'Anatomopathologie, Lille, France.; Buée L; University of Lille, INSERM, CHU Lille, UMR-S1172 LilNCog, Lille Neuroscience and Cognition, Lille, France.; Alzheimer and Tauopathies, LabEx DISTALZ, Lille, France.; Abbadie C; University of Lille, INSERM, CNRS, CHU Lille, UMR9020-U1277, CANTHER, Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.; Glowacki F; University of Lille, INSERM, CNRS, CHU Lille, UMR9020-U1277, CANTHER, Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.; CHU Lille, Service de Néphrologie, Lille, France.; Pottier N; University of Lille, INSERM, CNRS, CHU Lille, UMR9020-U1277, CANTHER, Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.; CHU Lille, Service de Toxicologie et Génopathies, Lille, France.; Perrais M; University of Lille, INSERM, CNRS, CHU Lille, UMR9020-U1277, CANTHER, Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.; Cunha RA; CNC, Center for Neuroscience and Cell Biology, University of Coimbra, Rua Larga, Faculty of Medicine Building-Polo 1, Coimbra, Portugal.; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.; Annicotte JS; University of Lille, INSERM, CNRS, CHU Lille, Institut Pasteur de Lille, INSERM U1283-UMR8199 - EGID, Lille, France.; University of Lille, INSERM, CHU Lille, Institut Pasteur de Lille, RID-AGE-Facteurs de risque et déterminants moléculaires des maladies liées au vieillissement, Lille, France.; Laumet G; Department of Physiology, Michigan State University, East Lansing, Michigan, USA.; Blum D; University of Lille, INSERM, CHU Lille, UMR-S1172 LilNCog, Lille Neuroscience and Cognition, Lille, France.; Alzheimer and Tauopathies, LabEx DISTALZ, Lille, France.; Cauffiez C; University of Lille, INSERM, CNRS, CHU Lille, UMR9020-U1277, CANTHER, Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.
Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Academic Journal
Boukrout N; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Souidi M; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Lahdaoui F; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Duchêne B; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Neve B; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Coppin L; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Leteurtre E; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Torrisani J; Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, F-31037 Toulouse, France.; Van Seuningen I; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Jonckheere N; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Academic Journal
Jonckheere N; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Auwercx J; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Laboratoire de Physiologie Cellulaire et Moléculaire-UR UPJV 4667, UFR Sciences, Université de Picardie Jules Verne (UPJV), 80039 Amiens, France.; Hadj Bachir E; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Coppin L; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Boukrout N; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Vincent A; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Neve B; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; Gautier M; Laboratoire de Physiologie Cellulaire et Moléculaire-UR UPJV 4667, UFR Sciences, Université de Picardie Jules Verne (UPJV), 80039 Amiens, France.; Treviño V; Cátedra de Bioinformática, Escuela de Medicina, Tecnologico de Monterrey, Monterrey 64710, Nuevo León, Mexico.; Van Seuningen I; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Academic Journal
Drubay V; INSERM, UMR-S1172, Jean Pierre Aubert Research Center, 'Mucins, Epithelial Differentiation and Carcinogenesis' Team, rue Polonovski, 59045 Lille CEDEX, France. v.drubay54@gmail.com.; UMR-S 1172-JPArc, Université Lille Nord de France, 1 Place de Verdun, 59045 Lille CEDEX, France. v.drubay54@gmail.com.; Centre Hospitalier Régional et Universitaire de Lille, Place de Verdun, 59037 Lille CEDEX, France. v.drubay54@gmail.com.; Skrypek N; INSERM, UMR-S1172, Jean Pierre Aubert Research Center, 'Mucins, Epithelial Differentiation and Carcinogenesis' Team, rue Polonovski, 59045 Lille CEDEX, France. nicolas.skrypek@gmail.com.; UMR-S 1172-JPArc, Université Lille Nord de France, 1 Place de Verdun, 59045 Lille CEDEX, France. nicolas.skrypek@gmail.com.; Centre Hospitalier Régional et Universitaire de Lille, Place de Verdun, 59037 Lille CEDEX, France. nicolas.skrypek@gmail.com.; Cordiez L; INSERM, UMR-S1172, Jean Pierre Aubert Research Center, 'Mucins, Epithelial Differentiation and Carcinogenesis' Team, rue Polonovski, 59045 Lille CEDEX, France. lucie.coppin@inserm.fr.; UMR-S 1172-JPArc, Université Lille Nord de France, 1 Place de Verdun, 59045 Lille CEDEX, France. lucie.coppin@inserm.fr.; Centre Hospitalier Régional et Universitaire de Lille, Place de Verdun, 59037 Lille CEDEX, France. lucie.coppin@inserm.fr.; Vasseur R; INSERM, UMR-S1172, Jean Pierre Aubert Research Center, 'Mucins, Epithelial Differentiation and Carcinogenesis' Team, rue Polonovski, 59045 Lille CEDEX, France. romain.vasseur@inserm.fr.; UMR-S 1172-JPArc, Université Lille Nord de France, 1 Place de Verdun, 59045 Lille CEDEX, France. romain.vasseur@inserm.fr.; Centre Hospitalier Régional et Universitaire de Lille, Place de Verdun, 59037 Lille CEDEX, France. romain.vasseur@inserm.fr.; Schulz C; INSERM, UMR-S1172, Jean Pierre Aubert Research Center, 'Mucins, Epithelial Differentiation and Carcinogenesis' Team, rue Polonovski, 59045 Lille CEDEX, France. celine.schulz@univ-lille.fr.; UMR-S 1172-JPArc, Université Lille Nord de France, 1 Place de Verdun, 59045 Lille CEDEX, France. celine.schulz@univ-lille.fr.; Centre Hospitalier Régional et Universitaire de Lille, Place de Verdun, 59037 Lille CEDEX, France. celine.schulz@univ-lille.fr.; CNRS, UMR 8576-UGSF-Unité de Glycobiologie Structurale et Fonctionnelle, Université de Lille, F 59000 Lille, France. celine.schulz@univ-lille.fr.; Boukrout N; INSERM, UMR-S1172, Jean Pierre Aubert Research Center, 'Mucins, Epithelial Differentiation and Carcinogenesis' Team, rue Polonovski, 59045 Lille CEDEX, France. nihad.boukrout@inserm.fr.; UMR-S 1172-JPArc, Université Lille Nord de France, 1 Place de Verdun, 59045 Lille CEDEX, France. nihad.boukrout@inserm.fr.; Centre Hospitalier Régional et Universitaire de Lille, Place de Verdun, 59037 Lille CEDEX, France. nihad.boukrout@inserm.fr.; Duchêne B; INSERM, UMR-S1172, Jean Pierre Aubert Research Center, 'Mucins, Epithelial Differentiation and Carcinogenesis' Team, rue Polonovski, 59045 Lille CEDEX, France. belinda.duchene@inserm.fr.; UMR-S 1172-JPArc, Université Lille Nord de France, 1 Place de Verdun, 59045 Lille CEDEX, France. belinda.duchene@inserm.fr.; Centre Hospitalier Régional et Universitaire de Lille, Place de Verdun, 59037 Lille CEDEX, France. belinda.duchene@inserm.fr.; Coppin L; INSERM, UMR-S1172, Jean Pierre Aubert Research Center, 'Mucins, Epithelial Differentiation and Carcinogenesis' Team, rue Polonovski, 59045 Lille CEDEX, France. lucie.cordiez@gmail.com.; UMR-S 1172-JPArc, Université Lille Nord de France, 1 Place de Verdun, 59045 Lille CEDEX, France. lucie.cordiez@gmail.com.; Centre Hospitalier Régional et Universitaire de Lille, Place de Verdun, 59037 Lille CEDEX, France. lucie.cordiez@gmail.com.; Van Seuningen I; INSERM, UMR-S1172, Jean Pierre Aubert Research Center, 'Mucins, Epithelial Differentiation and Carcinogenesis' Team, rue Polonovski, 59045 Lille CEDEX, France. isabelle.vanseuningen@inserm.fr.; UMR-S 1172-JPArc, Université Lille Nord de France, 1 Place de Verdun, 59045 Lille CEDEX, France. isabelle.vanseuningen@inserm.fr.; Centre Hospitalier Régional et Universitaire de Lille, Place de Verdun, 59037 Lille CEDEX, France. isabelle.vanseuningen@inserm.fr.; Jonckheere N; INSERM, UMR-S1172, Jean Pierre Aubert Research Center, 'Mucins, Epithelial Differentiation and Carcinogenesis' Team, rue Polonovski, 59045 Lille CEDEX, France. nicolas.jonckheere@inserm.fr.; UMR-S 1172-JPArc, Université Lille Nord de France, 1 Place de Verdun, 59045 Lille CEDEX, France. nicolas.jonckheere@inserm.fr.; Centre Hospitalier Régional et Universitaire de Lille, Place de Verdun, 59037 Lille CEDEX, France. nicolas.jonckheere@inserm.fr.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Boukrout, N.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어